The DOI matches its Crossref record.
Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nitrite metabolism can be activated by hypoxia, low pH and reactions with metalloproteins[50–58].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [50]
Citations
Cited by
Sorted by citations
Items 701–800 of 999
Comparison of responses to novel nitric oxide donors in the feline pulmonary vascular bed
Witt, B. J. D., Marrone, J. R., Kaye, A. D., Keefer, L. K., & Kadowitz, P. J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01289-4 · Cited by 31
Self-citationMingone, C. J., Gupte, S. A., Ali, N., et al. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00331.2005 · Cited by 31
“The early literature on the regulation of sGC has observations on how thiol oxidation can both enhance and inhibit basal cGMP production and sGC activation by agents thought to release NO (1, 3, 6, 14, 19, 22, 32, 35).”
BackgroundMethodNitroprusside, antihypertensive drug and analytical reagent
Leeuwenkamp, O. R., Bennekom, W. P. V., Mark, E. J. V. D., et al. (1984) · Pharmacy World & Science · doi:10.1007/bf01954040 · Cited by 31
Pérez‐Vizcaíno, F., Cogolludo, A. L., Villamor, E., et al. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701693 · Cited by 31
“Nitrovasodilators (organic nitrates and nitroprusside) exert their vasodilating e ects through the spontaneous or metabolic release of NO, or a closely related compound, from their molecule (Ignarro et al., 1981; Ignarro & Kadowitz, 1985; Murad, 1986; Feelisch, 1991).”
BackgroundChrist, G. J., Kim, D. C., Taub, H. C., Gondré, C. M., & Melman, A. (1995) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y95-735 · Cited by 29
Guanylate cyclase activation by organic nitrates in not mediated via nitrite
Romanin, C., & Kukovetz, W. R. (1988) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(88)80130-5 · Cited by 31
Sakanashi, M., Matsuzaki, T., & Aniya, Y. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12350.x · Cited by 31
The Effect of Inhaled Nitric Oxide in Pediatric Asthma
Pfeffer, K. D., Ellison, G., Robertson, D., et al. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564128 · Cited by 31
Konorev, E. A., Tarpey, M. M., Joseph, J., Baker, J. E., & Kalyanaraman, B. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)00112-w · Cited by 31
Vasorelaxant mechanism of the new vasodilator, FK409
Isono, T., Koibuchi, Y., Sato, N., et al. (1993) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(93)90032-5 · Cited by 31
Merkel, L. A., Rivera, L. M., Perrone, M. H., et al. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90205-i · Cited by 31
ATP-induced cochlear blood flow changes involve the nitric oxide pathway
Ren, T., Nuttall, A. L., & Miller, J. M. (1997) · Hearing Research · doi:10.1016/s0378-5955(97)00109-3 · Cited by 31
Biphasic relaxant curves to glyceryl trinitrate in rat aortic rings
Malta, E. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00165149 · Cited by 31
Novel Therapies for acute Respiratory Failure
Ring, J. C., & Stidham, G. L. (1994) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)38875-7 · Cited by 30
A Potential Role for Nitric Oxide in Myocardial Stunning
Hattler, B. G. J., Gorcsan, J., Shah, N., et al. (1994) · Journal of Cardiac Surgery · doi:10.1111/jocs.1994.9.3s.425 · Cited by 31
Molecular cardiology: New avenues for the diagnosis and treatment of cardiovascular disease
Hathaway, D. R., & March, K. L. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90498-1 · Cited by 31
Ginsenoside‐induced relaxation of human bronchial smooth muscle via release of nitric oxide
Tamaoki, J., Nakata, J., Kawatani, K., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703511 · Cited by 30
“Brie¯y, using the nitrosothiol NO donor Snitroso-N-acetyl-DL-penicillamine (SNAP) as a standard (Ignarro et al., 1981), the relationship between the magnitude of electrical current and the concentration of SNAP in the medium was determined.”
MethodThrombospondins: from structure to therapeutics
Roberts, D. D. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7483-2 · Cited by 32
Disulfide reductase systems in liver
Miller, C. G., & Schmidt, E. E. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14498 · Cited by 30
“NO was first recognized as a gaseous signalling molecule for its activities in vasodilation (Ignarro et al., 1981).”
BackgroundNitric Oxide as a Communication Signal in Vascular and Neuronal Cells
Ignarro, L. J. (1996) · Elsevier eBooks · doi:10.1016/b978-012435555-2/50004-8 · Cited by 30
Self-citationHayward, C. S., Kalnins, W. V., Rogers, P. G., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00143-5 · Cited by 30
Nitrate delivery systems in perspective
Abrams, J. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)91041-6 · Cited by 31
Tsutamoto, T., Kinoshita, M., Ohbayashi, Y., et al. (1994) · Circulation · doi:10.1161/01.cir.90.2.823 · Cited by 30
Kimura, K., & Nishio, I. (1999) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519950185724 · Cited by 30
Willerson, J. T., Igo, S. R., Yao, S.-K., et al. (1996) · PubMed · Cited by 30
Boesgaard, S., Inversen, H. K., Wroblewski, H., et al. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90515-0 · Cited by 30
Mehta, J. L., Mehta, P., Roberts, A. J., et al. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80301-5 · Cited by 30
Interval therapy to avoid nitrate tolerance: Paradise regained?
Abrams, J. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90844-8 · Cited by 30
Lang, D., & LEWIS, M. J. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12166.x · Cited by 31
Rapoport, R. M., & Murad, F. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90369-8 · Cited by 29
Sulfhydryl group donors potentiate the hypotensive effect of acetylcholine in rats.
Lahera, V., Khraibi, A. A., & Romero, J. C. (1993) · Hypertension · doi:10.1161/01.hyp.22.2.156 · Cited by 30
“Furthermore, sulfhydryl groups have been suggested as critical factors in the activation of guanylate cyclase by organic nitrates and NO through the formation of 5-nitrosothiols.(8) Studies of cultured endothelial cells using quantitative chemiluminescence techniques have reported that EDRF is more likely to be a nitr…”
BackgroundThe Role of Nitric Oxide in Migraine Pain
Thomsen, L. L., Iversen, H. K., Lassen, L. H., et al. (1994) · CNS Drugs · doi:10.2165/00023210-199402060-00002 · Cited by 30
Influence of S‐nitrosothiols and nitrate tolerance in the rat gastric fundus
Barbier, A., & Lefebvre, R. A. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14884.x · Cited by 30
Chung, S., & Fung, H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91716-4 · Cited by 29
Tsuchiya, K., Takiguchi, Y., Okamoto, M., Izawa, Y., Kanematsu, Y., Yoshizumi, M., & Tamaki, T. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fmj04006x3 · Cited by 29
Ignarro, L. J. (2000) · Elsevier eBooks · doi:10.1016/b978-012370420-7/50002-2 · Cited by 49
Self-citationScaffold-Free In Vitro Arterial Mimetics: The Importance of Smooth Muscle–Endothelium Contact
Chaterji, S., Park, K., & Panitch, A. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0271 · Cited by 29
“…mechanical forces, including pulsatile or cyclic strain 15 and shear stress 16,17 ; third, by introducing exogenous compounds in the culture medium 18,19 or even affording a repertoire of growth factors stemming from the use of media conditioned by other cell types, 20,21 including ECs 22 ; and…”
Differentiation of L- and D-S-Nitrosothiol Recognition Sites In Vivo
Lewis, S. J., Hoque, A., & Bates, J. N. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000181714.94827.5d · Cited by 29
“The differences in these responses may be related to the mechanisms by which these NO donors deliver NO to tissues or to additional mechanisms not necessarily related to NO delivery.(7,36,37) It was clear that the effects of NBT on the vasodilator actions of the test compounds were also not uniform.”
BackgroundInfluentialEmerging role of nitrite in myocardial protection
Lefer, D. J. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1804-y · Cited by 27
Nitrosothiol stores in vascular tissue: Modulation by ultraviolet light, acetylcholine and ionomycin
Ng, E. S. M., Cheng, Z. A., Ellis, A., Ding, H., Jiang, Y., Li, Y., Hollenberg, M. D., & Triggle, C. R. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.016 · Cited by 29
“It has been proposed that low molecular weight thiols such as glutathione and cysteine, which react with nitric oxide or oxides of nitrogen to form nitrosothiols, are potential candidates for such a nitric oxide-carrier molecule (Ignarro et al., 1981).”
BackgroundMatsumoto, T., Wada, A., Tsutamoto, T., et al. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.6.h1935 · Cited by 29
“NTG activates soluble guanylate cyclase, which results in increased cGMP production (9, 16, 22); NPs and NTG share a final common pathway through cGMP production.”
BackgroundHobbs, A. J. (2000) · Emerging Therapeutic Targets · doi:10.1517/14728222.4.6.735 · Cited by 29
Dubey, R. K., & Overbeck, H. W. (1994) · Cell and Tissue Research · doi:10.1007/bf00305381 · Cited by 29
“SNAP, an experimental drug that releases nitric oxide (NO) spontaneously in aqueous medium (Ignarro et al. 1981), significantly (P < 0.”
BackgroundFR144420, a novel, slow, nitric oxide-releasing agent
Kita, Y., Ohkubo, K., Hirasawa, Y., et al. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00750-2 · Cited by 29
A Pivotal Role of Nitric Oxide in Migraine Pain
Thomsen, L. L., & Olesen, J. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48642.x · Cited by 29
Interactions of Nitric Oxide and Redox-related species with biological targets
Maraj, S. R., Khan, S., Cui, X., Cammack, R., Joannou, C. L., & Hughes, M. (1995) · The Analyst · doi:10.1039/an9952000699 · Cited by 29
Feng, Q., & Hedner, T. (1990) · Clinical Physiology · doi:10.1111/j.1475-097x.1990.tb00822.x · Cited by 29
Tokita, Y., Bessho, Y., Masu, M., Nakamura, K. D., Nakao, K., Katsuki, M., & Nakanishi, S. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01168.x · Cited by 30
“However, these unique receptors represent a minority of AMPA receptors (Iino et al., 1990).”
BackgroundIn vitro studies of interactions of NO· donor drugs with superoxide and hydroxyl radicals
Dalloz, F., Maupoil, V., Lecour, S., Briot, F., & Rochette, L. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006821724773 · Cited by 29
“This complex inorganic salt which is rapidly inactivated in vivo [31], can spontaneously release NO· in neutral aqueous solutions [18, 28, 29, 30, 32], probably through a reductive mechanism of decomposition.”
BackgroundCabassi, A., Bouchard, J., Dumont, É. C., Girouard, H., Jossec, M. L., Lamontagne, D., Besner, J., & de Champlain, J. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018020-00009 · Cited by 29
Monge, L., García‐Villalón, A. L., Montoya, J. J., et al. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13531.x · Cited by 29
Osterloh, J., & Goldfield, D. (1984) · Journal of Liquid Chromatography · doi:10.1080/01483918408074000 · Cited by 29
Kawada, T., Ishibashi, T., Sasage, H., Kato, K., & Imai, S. (1994) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(94)90160-0 · Cited by 29
The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats
Jia, L., & Blantz, R. C. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00424-5 · Cited by 29
Bauer, J. A., & Fung, H. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199609000-00004 · Cited by 29
Newman, C. M., Warren, J. B., Taylor, G. W., Boobis, A. R., & Davies, D. S. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb13014.x · Cited by 27
Mozayan, M., Chen, M., Si, M.-L., et al. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600310 · Cited by 28
“Moreover, relaxation induced by sodium nitroprusside, which is known to release NO on entering the smooth muscle cells (Ignarro et al, 1981), was not affected by these three ChEIs either.”
BackgroundWang, H., Qin, Y., Li, H., Roman, L. J., Pavel Martasek, E., Poulos, T. L., & Silverman, R. B. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00273 · Cited by 30
Methods for detection and characterization of protein S-nitrosylation
Chen, Y., Ching, W.-C., Lin, Y., & Chen, Y. (2013) · Methods · doi:10.1016/j.ymeth.2013.04.016 · Cited by 29
Fluorophore-Labeled S-Nitrosothiols
Chen, X., Wen, Z., Xian, M., Wang, K., Ramachandran, N., Tang, X., Schlegel, H. B., Mutus, B., & Wang, P. G. (2001) · The Journal of Organic Chemistry · doi:10.1021/jo015658p · Cited by 28
Trauner, M., Nathanson, M. H., Mennone, A., Rydberg, S. A., & Boyer, J. L. (1997) · Hepatology · doi:10.1002/hep.510250202 · Cited by 28
Oliveira, A. P. S., & Bendhack, L. M. (2004) · Pharmacology · doi:10.1159/000080378 · Cited by 28
N-Acetylcysteine Potentiates Nitroglycerin-Induced Reversal of Platelet Aggregation
Chirkov, Y. Y., & Horowitz, J. D. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199609000-00005 · Cited by 28
Inactivation of human aldehyde dehydrogenase by isosorbide dinitrate.
Mukerjee, N., & Pietruszko, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31857-4 · Cited by 28
Developmental aspects of endothelial function.
Pearce, W. J., & Longo, L. D. (1991) · PubMed · Cited by 28
Matsuoka, I., Sakurai, K., Ono, T., & Nakanishi, H. (1987) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.44.23 · Cited by 26
Andreasen, L. V., Lorković, I. M., Richter-Addo, G. B., & Ford, P. C. (2002) · Nitric Oxide · doi:10.1006/niox.2001.0403 · Cited by 27
Differential mechanisms of urethral smooth muscle relaxation by several NO donors and nitric oxide
García-Pascual, Á., Costa, G., Labadía, A., Jimenez, E., & Triguero, D. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900038 · Cited by 27
Attenuation by nitrosothiol NO donors of acute intestinal microvascular dysfunction in the rat
László, F. A., Whittle, B. J. R., & Moncada, S. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16361.x · Cited by 28
Mechanisms of nitrate action and vascular tolerance
Fung, H. L., Chong, S., & Kowaluk, E. A. (1989) · European Heart Journal · doi:10.1093/eurheartj/10.suppl_a.2 · Cited by 28
Palomero, J., Pye, D., Kabayo, T., & Jackson, M. J. (2011) · Free Radical Research · doi:10.3109/10715762.2011.637203 · Cited by 27
“Exposure of muscle cells to SNAP (250 μ M), a nitric oxide donor, was used as a positive control [32].”
MethodYogaratnam, J. Z., Laden, G., Guvendik, L., Cowen, M., Cale, A. R. J., & Griffin, S. C. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.09.003 · Cited by 27
“While it can be appreciated that HBO2 is capable of producing NO [83] and that in the presence of superoxide, as may occur during treatment with HBO2 [94–96], NO may react with superoxide to produce peroxynitrite [61–64], which may go on to produce S-nitrosothiols that may also activate guanylate cyclase [78], how is…”
BackgroundHalasz, A., Thiboutot, S., Ampleman, G., & Hawari, J. A.-A. (2010) · Chemosphere · doi:10.1016/j.chemosphere.2010.01.013 · Cited by 27
“Nitric oxide has been described as an important degradation product inside mammalian cells and was identified of being responsible in the signaling mechanism in mammalian cells (Di Carlo, 1975; Ignarro et al., 1981; Ignarro, 2002; Kozlov et al., 2003).”
BackgroundEnhancing Cardiovascular Dynamics by Inhibition of Thrombospondin- 1/CD47 Signaling
Isenberg, J. S., Frazier, W. A., Krishna, M. C., Wink, D. A., & Roberts, D. D. (2008) · Current Drug Targets · doi:10.2174/138945008785909338 · Cited by 27
“These observations led to a search for the endothelial derived relaxing factor that controls smooth muscle contractility, which was found to be NO [14-17].”
BackgroundInducible Nitric Oxide Synthase and Apoptosis in Murine Proximal Tubule Epithelial Cells
Tiwari, M., Messer, K. J., & Mayeux, P. R. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj168 · Cited by 27
“These data support our in vivo findings in a murine model of LPS-induced ARF (Tiwari et al., 2005a) that suggest that iNOSinduced renal vascular dysfunction may play a more critical role in tubular injury and the development of LPS-induced ARF than direct tubular epithelium cytotoxicity.”
BackgroundMethodInfluentialRole of nitrates after acute myocardial infarction
Jugdutt, B. I. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90598-s · Cited by 27
Seçilmiş, M. A., Karataş, Y., Yorulmaz, Ö., et al. (2005) · Nephron Physiology · doi:10.1159/000084657 · Cited by 27
Haramaki, N., Ikeda, H., Takajo, Y., et al. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1001.097021 · Cited by 27
Suzuki, K., Takagi, K., Satake, T., et al. (1986) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1986.tb00313.x · Cited by 27
Satoh, M., Matsuo, K., Kiriya, H., et al. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00516-2 · Cited by 27
Endothelium-dependent relaxation resistant to NG-nitro-l-arginine in rat aorta
Hatake, K., Wakabayashi, I., & Hishida, S. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00704-b · Cited by 27
Effects of Maturation on Cyclic GMP-Dependent Vasodilation in Ovine Basilar and Carotid Arteries
Pearce, W. J., Hull, A., Long, D. M., et al. (1994) · Pediatric Research · doi:10.1203/00006450-199407001-00005 · Cited by 27
The Role of Nitric Oxide in Glial Pathologya
Mitrovic, B., Pierre, B. A. S., MacKenzie‐Graham, A. J., et al. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21835.x · Cited by 27
Leier, C. V. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90491-0 · Cited by 27
How does nitroglycerin induce vascular smooth muscle relaxation?
Bennett, B. M., & Marks, G. S. (1984) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(84)90461-9 · Cited by 27
Albers, I., Zernickel, E., Stern, M. E., Broja, M., Busch, H. L., Heiß, C., Grotheer, V., Windolf, J., & Suschek, C. V. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.022 · Cited by 25
Effects of endogenous ligands on the biological role of human serum albumin in S-nitrosylation
Ishima, Y., Akaike, T., Kragh‐Hansen, U., Hiroyama, S., Sawa, T., Maruyama, T., Kai, T., & Otagiri, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.094 · Cited by 26
Effect of nitroglycerin administration on cardio-ankle vascular index
Shimizu, K., Yamamoto, T., Takahashi, M., Sato, S., Noike, H., & Shirai, K. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s106542 · Cited by 26
A New Perspective on the Nitrate–Phosphodiesterase Type 5 Inhibitor Interaction
Kloner, R. A., Goggin, P., Goldstein, I., Hackett, G. I., Kirby, M. G., Osterloh, I. H., Parker, J. D., & D, R. S. M. (2018) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248418771896 · Cited by 26
Mondoro, T. H., Ryan, B. A. B., Hrinczenko, B. W., Schechter, A. N., Vostal, J. G., & Alayash, A. I. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02623.x · Cited by 26
“This compound has relaxant properties as well as antioxidant and antibacterial activities (Ignarro et al, 1981; Feelisch & Stamler, 1996).”
BackgroundOral Nitrates: More Than Symptomatic Therapy in Coronary Artery Disease?
Thadani, U. (1997) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007750706831 · Cited by 24
Protamine induces endothelium-dependent vasodilatation of the pulmonary artery
Évora, P. R. B., Pearson, P. J., & Schaff, H. V. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00400-f · Cited by 26
“Since then, the active component of this relaxing factor has been identif ied to be the nitric oxide radical [18, 19], which is also the active component of ni trovasodilators such as sodium ni t ropruss ide and nitroglycerin [28].”
BackgroundSand, A., ANDERSSON, E., & Fried, G. M. (2002) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2002.00939.x · Cited by 26
Kojda, G., Beck, J. K., Meyer, W., et al. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13106.x · Cited by 26
Man, J. G. D., Boeckxstaens, G. E., Winter, B. Y. D., et al. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13331.x · Cited by 26
Ignarro, L. J., & Wood, K. S. (1987) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(87)90117-0 · Cited by 26
Self-citationRandall, M. D., & Hiley, C. R. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11612.x · Cited by 26
N-Acetylcysteine Does Not Influence the Activity of Endothelium-Derived Relaxing Factor In Vivo
Creager, M. A., Roddy, M.-A., Boles, K., & Stamler, J. S. (1997) · Hypertension · doi:10.1161/01.hyp.29.2.668 · Cited by 25
Routes for Formation of S-Nitrosothiols in Blood
Nagababu, E., & Rifkind, J. M. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9321-2 · Cited by 25
Chang, W., Chung, C., Wu, Y., et al. (2004) · Nitric Oxide · doi:10.1016/j.niox.2004.10.004 · Cited by 25
Metadata
- Authors
- Ignarro, L. J., Lippton, H., Edwards, J. C., Baricos, W. H., Hyman, A. L., Kadowitz, P. J., & Gruetter, C. A.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1981-09
- Volume
- 218
- Issue
- 3
- Pages
- 739-749
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W1907994445
- Cited by
- 1,633
- References
- 0
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 2 · 2023: 10 · 2022: 11 · 2021: 6 · 2020: 8 · 2019: 14 · 2018: 23 · 2017: 10 · 2016: 15 · 2015: 16 · 2014: 14 · 2013: 16 · 2012: 27
- FWCI
- 18.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- vasorelaxation, organic nitrates, nitrite, sodium nitroprusside, nitric oxide, S-nitrosothiols, guanylate cyclase activation, cyclic GMP, nitroglycerin, isosorbide dinitrate, PETN, amyl nitrite, sodium nitrite, sulfhydryl groups, coronary arteries
- MeSH terms
- Animals, Biotransformation, Cats, Cattle, Coronary Vessels, Enzyme Activation, Female, Ferricyanides, Guanylate Cyclase, Hemodynamics, Male, Nitrates, Nitric Oxide, Nitrites, Nitroprusside, Nitroso Compounds, Vasodilator Agents, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review